Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study. — CFSMEATLAS
Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study.
Perez, Melanie, Jaundoo, Rajeev, Hilton, Kelly et al. · Frontiers in pediatrics · 2019 · DOI
Quick Summary
Researchers analyzed the DNA of 383 ME/CFS patients to look for genetic variations that might make someone more susceptible to developing the illness. They found thousands of genetic differences that were more common in ME/CFS patients compared to the general population, and these differences clustered in three main areas: immune system function, hormone regulation, and metabolism. While this suggests genetics may play a role in ME/CFS vulnerability, it doesn't explain the entire cause of the disease.
Why It Matters
This study provides preliminary evidence that genetic predisposition may contribute to ME/CFS pathogenesis, suggesting biological vulnerability rather than purely psychological origins. Understanding genetic risk factors could eventually lead to better patient stratification, early identification of at-risk individuals, and targeted therapies addressing underlying immune and metabolic dysfunction.
Observed Findings
5,693 genetic variants showed at least 10% frequency with at least two-fold higher frequency in the ME/CFS cohort compared to reference populations.
Genetic variants were predominantly located in genes related to immune system, hormone regulation, metabolic pathways, and extracellular matrix organization.
517 of these variants were classified as highly deleterious based on CADD scoring, placing them in the top 10% of potentially damaging genetic substitutions.
The genetic signature suggested dysfunction across multiple physiological systems rather than abnormality in a single pathway.
Inferred Conclusions
Genetic predisposition affecting immune, hormonal, and metabolic function may contribute to ME/CFS vulnerability.
The multisystem genetic pattern supports ME/CFS as a complex, multifactorial illness rather than a single-system disorder.
Further investigation of these genetic pathways could identify biological mechanisms underlying ME/CFS pathogenesis.
Remaining Questions
Do these genetic variants increase disease risk independently, or only in combination with environmental triggers or infections?
How do these genetic variants translate into the specific physiological abnormalities observed in ME/CFS patients?
What This Study Does Not Prove
This study does not establish that these genetic variants cause ME/CFS—it only shows associations in one cohort. The findings have not been validated in independent populations, and the presence of a genetic variant does not determine whether someone will develop the disease. Additionally, this pilot study cannot explain how genetic variants trigger illness onset or why environmental factors appear necessary for disease development.